Sleep Medicine

  • Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
    CME article
    Vania Modesto-Lowe, MD, MPH, Margaret M. Chaplin, MD, Roberto León-Barriera, MD and Lakshit Jain, MD
    Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299; DOI: https://doi.org/10.3949/ccjm.91a.23061

    The authors review measures for preventing harm before benzodiazepines are prescribed, decreasing harm within 4 weeks after they are prescribed, and limiting harmful effects of long-term prescribing.

  • ‘Guidelines to Practice’ series: Asthma in adults
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 365; DOI: https://doi.org/10.3949/ccjm.88b.07021

    A clinically useful summary, highlighting the practical and newer conceptual aspects of the guidelines.

  • Outpatient management of asthma in adults: A snapshot of the 2020 GINA report
    Kavya Kommaraju, MD and Mani Latifi, MD
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 377-380; DOI: https://doi.org/10.3949/ccjm.88a.20167

    A review of the guidelines, with a focus on what’s new and clinically important.

  • Quetiapine for primary insomnia: Consider the risks
    Vania Modesto-Lowe, MD, MPH, Agata K. Harabasz, MD and Sophia A. Walker, MD
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 286-294; DOI: https://doi.org/10.3949/ccjm.88a.20031

    Its cardiometabolic effects and potential for abuse warrant caution in off-label use.

  • Is regular oxygen supplementation safe for obese postoperative patients?
    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727; DOI: https://doi.org/10.3949/ccjm.87a.19051

    Caution for some, but no evidence to support withholding it altogether.

  • Beyond depression: Other uses for tricyclic antidepressants
    Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

    The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  • A link between A-fib and sleep apnea is no surprise, but why?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 706-707; DOI: https://doi.org/10.3949/ccjm.86b.11019

    The two conditions commonly coexist, and treating the sleep apnea results in better rhythm-directed outcomes in the A-fib.

  • Should I evaluate my patient with atrial fibrillation for sleep apnea?
    Mirna B. Ayache, MD, MPH, Reena Mehra, MD, MS, FCCP, FAASM and Kenneth A. Mayuga, MD, FACC, FHRS
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 709-712; DOI: https://doi.org/10.3949/ccjm.86a.19033

    Yes. The prevalence of sleep apnea is high in patients with atrial fibrillation, and vice versa.

  • SEEDS for success: Lifestyle management in migraine
    Jennifer Robblee, MD, MSc and Amaal J. Starling, MD
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 741-749; DOI: https://doi.org/10.3949/ccjm.86a.19009

    Lifestyle counseling can be based on the mnemonic SEEDS: sleep, exercise, eat, diary, and stress.

  • What are the risks to inpatients during hospital construction or renovation?
    Amjad Kanj, MD, Yuqing Gao, MD and Ayman O. Soubani, MD
    Cleveland Clinic Journal of Medicine October 2019, 86 (10) 650-652; DOI: https://doi.org/10.3949/ccjm.86a.19008

    Risks include mold infection, Legionnaires disease, sleep deprivation, exacerbation of lung disease, and physical injury.

Pages